F001 The Future of Dermatology: What Changes Are Coming and How Can We Prepare?
DESCRIPTION
The session will focus on the latest events and advocacy updates in Dermatology. Issues including title misappropriation, scope of practice and truth in advertising, issues with private insurers/Medicare, access to prescription medication/OTC products, AI updates, Pediatric Dermatology, and ensuring diversity in dermatology will be discussed.
LEARNING OBJECTIVES
Evaluate and assess resources to manage your practice optimally during the ongoing “New Normal”.
Adapt stratifies to navigate rapidly changing regulatory rules affecting our ability to deliver patient care and obtain reimbursement.
As Board Certified/Eligible Dermatologists and leaders of the Dermatology Care Team anticipate the future of Dermatology by embracing strategies to ensure patient safety, truth in advertising, and maintenance of standards of care.
SCHEDULE
9:00 AM
TBD
DIRECTOR
Sabra Sullivan, MD, PhD, FAAD
SPEAKERS
Bruce A. Brod, MHCI, MD, FAAD
Brett M. Coldiron, MD, FAAD
Thy Nhat Huynh, MD, FAAD
Klint Peebles, MD, FAAD
Melissa Piliang, MD, FAAD
DISCLOSURES
Bruce A. Brod, MHCI, MD, FAAD
No financial relationships exist with ineligible companies.
Brett M. Coldiron, MD, FAAD
No financial relationships exist with ineligible companies.
Thy Nhat Huynh, MD, FAAD
No financial relationships exist with ineligible companies.
Klint Peebles, MD, FAAD
Kaiser Permanente – Employee(Salary);
Melissa Piliang, MD, FAAD
AbbVie – Advisory Board(Honoraria), Investigator(No Compensation Received); Eli Lilly and Company – Investigator(No Compensation Received), Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(No Compensation Received), Speaker(Honoraria); Procter & Gamble Company – Consultant(Honoraria); Sanofi – Investigator(No Compensation Received);
Sabra Sullivan, MD, PhD, FAAD
No financial relationships exist with ineligible companies.